Manager TitleAgeSince
Chief Executive Officer 86 01/09/2013
Director of Finance/CFO 55 01/10/2012
Director TitleAgeSince
Chairman 54 12/08/2021
Director/Board Member 45 -
Director/Board Member 54 -
Change 5-day change 1-year change 3-year change Capi.($)
+99,900.00%-60.00% - - 1L
-1.40%+2.59%-1.71%+11.28% 4.85TCr
-2.41%-0.90%+411.96%+495.33% 3.99TCr
-1.16%+12.96%+28.81%+7.25% 3.87TCr
-1.88%-3.03%+5.69%+53.00% 3.51TCr
-1.74%+5.12%+14.44%+41.77% 2.98TCr
-0.21%-4.04%+36.40%+125.75% 1.61TCr
-2.85%-3.92% - - 1.61TCr
-0.64%+2.65%+3.40%+13.11% 1.36TCr
-1.19%-1.32%-1.73%-34.37% 1.26TCr
Average +9,988.65%+1.05%+62.16%+89.14% 2.78TCr
Weighted average by Cap. -1.55%+2.03%+79.78%+108.61%

Financials

2020 2021
Net sales 15.02L 17.28L 13.98L 12.84L 24.24L 16Cr 24.62L 1.65Cr 64.69L 8.21Cr 64.9L 63.48L 28Cr 10.77L 12.39L 10.03L 9L 17.38L 12Cr 17.65L 1.18Cr 46.38L 5.89Cr 46.54L 45.51L 20Cr
Net income 1.47Cr 1.7Cr 1.37Cr 1.26Cr 2.38Cr 161.94Cr 2.42Cr 16Cr 6.35Cr 81Cr 6.37Cr 6.23Cr 270.33Cr -1.06Cr -1.22Cr -98.42L -90.36L -1.71Cr -116.12Cr -1.73Cr -12Cr -4.55Cr -58Cr -4.57Cr -4.47Cr -193.84Cr
Net Debt - -
Logo MagForce AG
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.
Employees
33